Oragenics(GB:0A64)
$5.130.00 (0.00%)
GB:0A64
Oragenics stock drug pipeline
$5.13
At close:0.00 (0.00%)
Oragenics (0A64) Drug Pipeline
1 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Neurosteroid Enantiomer | Mild Traumatic Brain Injury, Concussion | Phase II | Not Yet Recruiting | A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury | Mar 05, 2025 | ― |
| Ag013 | Oral Mucositis | Phase II | Terminated | Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day | Jul 21, 2017 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Neurosteroid Enantiomer | Phase II | Mild Traumatic Brain Injury, Concussion | Not Yet Recruiting | A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury | Mar 05, 2025 | ― |
| Ag013 | Phase II | Oral Mucositis | Terminated | Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day | Jul 21, 2017 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Oragenics Inc (GB:0A64) have in its pipeline
Oragenics GB:0A64 is currently developing the following drugs: Neurosteroid Enantiomer, Ag013. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

